Indications for: ERVEBO

Prevention of disease due to Zaire ebolavirus.

Limitations of Use:

The duration of protection conferred by Ervebo is unknown. Does not protect against other species of Ebolavirus or Marburgvirus. Effectiveness of the vaccine when administered concurrently with antiviral medication, immuneglobulin, and/or blood or plasma transfusions is unknown.

Adult Dosage:

Give by IM inj, preferably in deltoid region of the non-dominant arm. ≥18yrs: administer one (1mL) dose.

Children Dosage:

<18yrs: not established.

ERVEBO Contraindications:

Allergy to rice protein.

ERVEBO Warnings/Precautions:

Immunization may not protect all individuals. Have appropriate medical treatment and supervision available to manage allergic reactions. Immunocompromised. Possible transmission of vaccine virus. Pregnancy. Nursing mothers.

ERVEBO Classification:

Ebola Zaire vaccine.

ERVEBO Interactions:

May test (+) results for anti-Ebola glycoprotein (GP) antibody and/or Ebola GP nucleic acid or antigens.

Adverse Reactions:

Inj site reactions (pain, swelling, redness), headache, feverishness, muscle pain, fatigue, joint pain, nausea, arthritis, rash, abnormal sweating.

Generic Drug Availability:


How Supplied:

Single-dose vials—10